77672421 - MONDORARE

Information

• Trademark
• 77672421

• Source

• Serial Number

  77672421

• Registration Number

  4007941

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 17, 2009
  16 years ago

• Registration Date

  August 09, 2011
  13 years ago

• Transaction Date

  April 24, 2018
  6 years ago

• Status Date

  March 16, 2018
  6 years ago

• Published for Opposition Date

  May 24, 2011
  13 years ago

• Location Date

  August 09, 2011
  13 years ago

• Status Code

  710

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  NELSON, EDWARD H

• Attorney Docket Number

  01492-US-549

  Attorney Name

  James A. Long

  Law Office Assigned Location Code

  L60

• Owners

  • MONDOBIOTECH LABORATORIES AG

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment or prophylaxis of infectious diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of immunological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of autoimmune diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of cardiovascular diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of inflammatory diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of neurological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of psychiatric diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of eye diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of dental diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of kidney diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of liver diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of metabolic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of gynecological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of andrological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of urologic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of geriatric diseases and states in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of orthopaedic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of muscular diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of skin diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of pain in humans or animals; pharmaceutical preparations for the treatment of and preparation to surgical states in humans or animals; pharmaceutical preparations for anaesthesia in humans or animals; pharmaceutical preparations for obstetrics or abortion in humans or animals; pharmaceutical preparations for cosmetic purposes in humans or animals; Pharmaceutical preparations for treating respiratory diseases and asthma; Pharmaceutical preparations for treatment of pulmonary diseases; Pharmaceutical preparations for the treatment of hypertension; Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Biological preparations for medical purposes; Biological preparations for veterinary purposes; Bronchodilating preparations; Veterinary preparations for the treatment of infectious diseases; Veterinary preparations for the treatment of non-infectious diseases; pharmaceutical preparations, namely, contrast agents for radiography, x-ray radiography, computer tomography, magnetic resonance imaging, magnetic resonance tomography, ultrasonography or positron emission tomography; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Chemical reagents for medical or veterinary purposes; Chemico-pharmaceutical preparations for the treatment or prophylaxis of infectious diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of immunological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of autoimmune diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of cardiovascular diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of inflammatory diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of neurological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of psychiatric diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of eye diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of dental diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of kidney diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of liver diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of metabolic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of gynecological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of andrological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of urologic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of geriatric diseases and states in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of orthopaedic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of muscular diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of skin diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of pain in humans or animals; Chemico-pharmaceutical preparations for the treatment of and preparation to surgical states in humans or animals; Chemico-pharmaceutical preparations for anaesthesia in humans or animals; Chemico-pharmaceutical preparations for obstetrics or abortion in humans or animals; Chemico-pharmaceutical preparations for cosmetic purposes in humans or animals; Diagnostic preparations for clinical or medical use; Diagnostic preparations for veterinary use; Dietetic substances adapted for medical use; Disinfectants; Preparations for destroying vermin; Fungicides; Herbicides; Drugs for medical purposes; Medicines for the treatment or prophylaxis of dental diseases and states and dental cosmetic purposes; Medicines for the treatment or prophylaxis of infectious diseases in humans or animals; Medicines for the treatment or prophylaxis of immunological diseases in humans or animals; Medicines for the treatment or prophylaxis of autoimmune diseases in humans or animals; Medicines for the treatment or prophylaxis of cardiovascular diseases in humans or animals; Medicines for the treatment or prophylaxis of inflammatory diseases in humans or animals; Medicines for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; Medicines for the treatment or prophylaxis of neurological diseases in humans or animals; Medicines for the treatment or prophylaxis of psychiatric diseases in humans or animals; Medicines for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; Medicines for the treatment or prophylaxis of eye diseases in humans or animals; Medicines for the treatment or prophylaxis of dental diseases in humans or animals; Medicines for the treatment or prophylaxis of kidney diseases in humans or animals; Medicines for the treatment or prophylaxis of liver diseases in humans or animals; Medicines for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; Medicines for the treatment or prophylaxis of metabolic diseases in humans or animals; Medicines for the treatment or prophylaxis of gynecological diseases in humans or animals; Medicines for the treatment or prophylaxis of andrological diseases in humans or animals; Medicines for the treatment or prophylaxis of urologic diseases in humans or animals; Medicines for the treatment or prophylaxis of geriatric diseases and states in humans or animals; Medicines for the treatment or prophylaxis of orthopaedic diseases in humans or animals; Medicines for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; Medicines for the treatment or prophylaxis of muscular diseases in humans or animals; Medicines for the treatment or prophylaxis of skin diseases in humans or animals; Medicines for the treatment or prophylaxis of pain in humans or animals; Medicines for the treatment of and preparation to surgical states in humans or animals; Medicines for anaesthesia in humans or animals; Medicines for obstetrics or abortion in humans or animals; Medicines for cosmetic purposes in humans or animals; Medical preparations for mouth care; Medical preparations for skin care; Sanitary preparations for medical use
• GS0351: Business appraisals; Business consulting services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business information services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business inquiry services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business investigation services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management and organization services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management assistance services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management consultancy services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business organization consultancy services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business acquisition and merger consultation in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Procurement of legal and technical know-how (franchising) in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Procurement of scientific cooperations in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Providing business consulting and management services for the commercialization of scientific projects in the field of medicine, pharmacy, biology, chemistry or medicine-technology
• GS0411: Providing of training in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of colloquiums in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of conferences in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of congresses in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of seminars in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of symposiums in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of workshops training in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Correspondence courses in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Educational services, namely, providing courses of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Organization of exhibitions for cultural or educational purposes; Practical training demonstration in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology
• GS0421: Biological research; Chemical analysis; Chemical Research; Chemistry services, namely, performing commissioned preparations, syntheses, patent search and literature search in the field of chemistry; Cosmetic research; Technical research in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Project studies Technical in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Medical and scientific development and research services in the field of medical, biochemical, pharmaceutical and medicine-technological research; Commissioned research and development work in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Commissioned development of pharmaceutical preparations; Medical and scientific research, namely, conducting and evaluating clinical trials of pharmaceutical preparations for statutory approval; Assessment of scientific projects, namely, evaluating their feasibility, scientific value and costs; Assessment of clinical studies and clinical trials; medical, bacteriological and biochemical laboratory services for diagnosis, analysis, research and drug development in the field of medicine
• GS0441: Services of a hospital; Services of medical practitioner; Services of a medical clinic; Pharmacy advice in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry, medicine-technology, health policy, business administration or related legal affairs; Medical assistance services; Nursing services; Medical sample testing services for samples provided by patients, volunteers, persons compelled by law, persons compelled by military institutions, persons compelled by educational institutions or employers to provide body samples for diagnostic purposes, treatment purposes and fitness evaluation
• PM0000: MONDO RARE

Case File Event Statements

• 3/16/2018 - 6 years ago

  44 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 8/9/2011 - 13 years ago

  43 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/24/2011 - 13 years ago

  42 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/24/2011 - 13 years ago

  41 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/21/2011 - 13 years ago

  40 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/19/2011 - 13 years ago

  39 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/19/2011 - 13 years ago

  38 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/19/2011 - 13 years ago

  37 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/19/2011 - 13 years ago

  36 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/19/2011 - 13 years ago

  35 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/19/2011 - 13 years ago

  34 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 4/15/2011 - 13 years ago

  33 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 4/2/2011 - 13 years ago

  32 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/1/2011 - 13 years ago

  31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/11/2011 - 14 years ago

  30 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/10/2011 - 14 years ago

  29 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/10/2011 - 14 years ago

  28 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/10/2011 - 14 years ago

  27 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/8/2010 - 14 years ago

  26 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 10/8/2010 - 14 years ago

  25 - FINAL REFUSAL E-MAILED Type: GNFR

• 10/8/2010 - 14 years ago

  24 - FINAL REFUSAL WRITTEN Type: CNFR

• 9/17/2010 - 14 years ago

  23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/17/2010 - 14 years ago

  22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/17/2010 - 14 years ago

  21 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/23/2010 - 14 years ago

  20 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/23/2010 - 14 years ago

  19 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/23/2010 - 14 years ago

  18 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/26/2010 - 15 years ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/26/2010 - 15 years ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/26/2010 - 15 years ago

  15 - ASSIGNED TO LIE Type: ALIE

• 1/28/2010 - 15 years ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/17/2009 - 15 years ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/17/2009 - 15 years ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/17/2009 - 15 years ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/25/2009 - 15 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/25/2009 - 15 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/25/2009 - 15 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/8/2009 - 15 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/8/2009 - 15 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/8/2009 - 15 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/7/2009 - 15 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 2/21/2009 - 16 years ago

  3 - NOTICE OF PSEUDO MARK MAILED Type: MPMK

• 2/20/2009 - 16 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 2/20/2009 - 16 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP